GLENMEDE TRUST CO NA - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$573,307
+122.8%
8,203
+96.6%
0.00%
+200.0%
Q2 2023$257,3280.0%4,1720.0%0.00%0.0%
Q1 2023$257,328
-49.2%
4,172
-36.4%
0.00%
-66.7%
Q4 2022$506,127
-27.1%
6,562
-57.8%
0.00%
-25.0%
Q3 2022$694,000
+219.8%
15,561
+173.7%
0.00%
+300.0%
Q2 2022$217,000
+3.8%
5,685
+2.7%
0.00%0.0%
Q4 2021$209,000
-43.7%
5,535
+0.6%
0.00%
-50.0%
Q2 2021$371,000
+14.5%
5,500
-4.1%
0.00%0.0%
Q1 2021$324,000
-29.9%
5,735
+1.1%
0.00%
-33.3%
Q4 2020$462,000
+26.9%
5,675
+11.0%
0.00%
+50.0%
Q3 2020$364,000
+68.5%
5,113
+94.2%
0.00%
+100.0%
Q2 2020$216,000
-59.0%
2,633
-48.4%
0.00%
-50.0%
Q1 2020$527,0000.0%5,1060.0%0.00%0.0%
Q4 2019$527,000
+335.5%
5,106
-15.0%
0.00%
+100.0%
Q3 2019$121,000
+36.0%
6,005
+73.6%
0.00%
Q2 2019$89,0003,4600.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,009,799$82,268,00041.24%
Fairmount Funds Management LLC 220,098$17,931,0006.41%
WMS Partners, LLC 250,000$20,368,0003.51%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,064,158$168,167,0003.06%
MORGAN JESS S & CO INC 44,468$3,623,0002.88%
RTW INVESTMENTS, LP 1,672,416$136,252,0002.29%
RA Capital Management 1,655,447$134,869,0001.88%
Nicholas Investment Partners, LP 207,452$16,901,0001.30%
Affinity Asset Advisors, LLC 25,000$2,037,0001.08%
Parkman Healthcare Partners LLC 30,758$2,506,0000.64%
View complete list of AXSOME THERAPEUTICS INC shareholders